Meet Symbiosis at BioForward 2026, connecting the UK’s biotechnology community with the partners driving innovation and commercial success.
BioForward brings together biotechnology companies, pharmaceutical organisations, investors and industry experts to accelerate innovation across the UK life sciences sector. Focused on collaboration, investment and advancing breakthrough therapies, the event provides an excellent opportunity to build new partnerships and explore solutions that support successful drug development.
As a specialist CDMO providing GMP aseptic fill-finish services for injectable biopharmaceuticals, Symbiosis looks forward to meeting organisations developing innovative biologics and advanced therapies. Whether you are progressing an early-stage programme, preparing for clinical manufacture or planning for commercial supply, our team will be happy to discuss how our integrated development and manufacturing services can support your project.
